News
ASCO 2025: Safety and Pharmacokinetics of Mevrometostat in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer (UroToday.com) The 2025 American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback